Click on image to view larger version.

Figure 2 Nitroglycerin-induced dilation (NMD) values of seven patients with hypercholesterolemia at baseline (BL I, II) after combined lipid-lowering and antioxidant therapy (Comb I, II) and after single lipid-lowering therapy (Statin).